Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
February 10, 2016
|
| In: |
The lancet
Year: 2016, Volume: 387, Issue: 10028, Pages: 1629-1637 |
| ISSN: | 1474-547X |
| DOI: | 10.1016/S0140-6736(15)01283-0 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1016/S0140-6736(15)01283-0 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0140673615012830 
|
| Author Notes: | Patrick Schöffski, Sant Chawla, Robert G. Maki, Antoine Italiano, Hans Gelderblom, Edwin Choy, Giovanni Grignani, Veridiana Camargo, Sebastian Bauer, Sun Young Rha, Jean-Yves Blay, Peter Hohenberger, David D'Adamo, Matthew Guo, Bartosz Chmielowski, Axel Le Cesne, George D. Demetri, Shreyaskumar R. Patel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1681412551 | ||
| 003 | DE-627 | ||
| 005 | 20220817021127.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191107s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(15)01283-0 |2 doi | |
| 035 | |a (DE-627)1681412551 | ||
| 035 | |a (DE-599)KXP1681412551 | ||
| 035 | |a (OCoLC)1341250481 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schöffski, Patrick |d 1963- |e VerfasserIn |0 (DE-588)130338133 |0 (DE-627)497997185 |0 (DE-576)298135639 |4 aut | |
| 245 | 1 | 0 | |a Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma |b a randomised, open-label, multicentre, phase 3 trial |c Patrick Schöffski, Sant Chawla, Robert G. Maki, Antoine Italiano, Hans Gelderblom, Edwin Choy, Giovanni Grignani, Veridiana Camargo, Sebastian Bauer, Sun Young Rha, Jean-Yves Blay, Peter Hohenberger, David D'Adamo, Matthew Guo, Bartosz Chmielowski, Axel Le Cesne, George D. Demetri, Shreyaskumar R. Patel |
| 264 | 1 | |c February 10, 2016 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.11.2019 | ||
| 700 | 1 | |a Hohenberger, Peter |d 1953- |e VerfasserIn |0 (DE-588)1025311469 |0 (DE-627)72202875X |0 (DE-576)370195574 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet |d London [u.a.] : Elsevier, 1823 |g 387(2016), 10028, Seite 1629-1637 |h Online-Ressource |w (DE-627)270128484 |w (DE-600)1476593-7 |w (DE-576)078590159 |x 1474-547X |7 nnas |a Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma a randomised, open-label, multicentre, phase 3 trial |
| 773 | 1 | 8 | |g volume:387 |g year:2016 |g number:10028 |g pages:1629-1637 |g extent:9 |a Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma a randomised, open-label, multicentre, phase 3 trial |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0140-6736(15)01283-0 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0140673615012830 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20191107 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1025311469 |a Hohenberger, Peter |m 1025311469:Hohenberger, Peter |d 60000 |d 61800 |e 60000PH1025311469 |e 61800PH1025311469 |k 0/60000/ |k 1/60000/61800/ |p 12 | ||
| 999 | |a KXP-PPN1681412551 |e 3538351821 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"February 10, 2016"}],"id":{"eki":["1681412551"],"doi":["10.1016/S0140-6736(15)01283-0"]},"relHost":[{"id":{"zdb":["1476593-7"],"issn":["1474-547X"],"eki":["270128484"]},"origin":[{"dateIssuedDisp":"1823-","publisherPlace":"London [u.a.] ; London","publisher":"Elsevier ; The Lancet Ltd.","dateIssuedKey":"1823"}],"part":{"volume":"387","pages":"1629-1637","text":"387(2016), 10028, Seite 1629-1637","issue":"10028","year":"2016","extent":"9"},"pubHistory":["1.1823 -"],"titleAlt":[{"title":"The lancet <London>"},{"title":"London lancet"},{"title":"Lancet (British ed. Online)"}],"title":[{"title_sort":"lancet","title":"The lancet"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"270128484","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma a randomised, open-label, multicentre, phase 3 trialThe lancet"}],"recId":"1681412551","language":["eng"],"physDesc":[{"extent":"9 S."}],"person":[{"family":"Schöffski","given":"Patrick","display":"Schöffski, Patrick","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Hohenberger, Peter","family":"Hohenberger","given":"Peter"}],"note":["Gesehen am 07.11.2019"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"subtitle":"a randomised, open-label, multicentre, phase 3 trial","title":"Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma","title_sort":"Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma"}],"name":{"displayForm":["Patrick Schöffski, Sant Chawla, Robert G. Maki, Antoine Italiano, Hans Gelderblom, Edwin Choy, Giovanni Grignani, Veridiana Camargo, Sebastian Bauer, Sun Young Rha, Jean-Yves Blay, Peter Hohenberger, David D'Adamo, Matthew Guo, Bartosz Chmielowski, Axel Le Cesne, George D. Demetri, Shreyaskumar R. Patel"]}} | ||
| SRT | |a SCHOEFFSKIERIBULINVE1020 | ||